Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Developing novel memristive systems aims to implement key principles of biological neuron assemblies - plasticity, adaptivity, and self-organization - into artificial devices for parallel, energy-efficient computing. Solid-state memristive devices, such as crossbar arrays and percolated nanoparticle (NP) networks, already demonstrate these properties. However, closer similarity to neural networks is expected from liquid-state systems, including polymer melts, which remain largely unexplored. Here, the resistive switching in silver/poly(ethylene glycol) (Ag/PEG) nanofluids, prepared by depositing gas-aggregated Ag NPs into PEGs of varying molecular mass, is investigated. These systems form long-range conductive NP bridges with reconfigurable resistance states in response to an electric field. The zeta-potential of Ag NPs and molecular mobility of PEG determine the prevalence of low resistance (ohmic) state, high resistance states (poor conductance) or intermediate transition states governed by space-charge-limited conduction or electron tunneling. The occurrence of these states is given by the interparticle gaps, which are determined by the conformation of PEG molecules adsorbed on the NPs. It is presented, for the first time, an equivalent circuit model for the Ag/PEG system. These findings pave the way to adopt polymer melts as matrices for neuromorphic engineering and bio-inspired electronics.

Download full-text PDF

Source
http://dx.doi.org/10.1002/advs.202505103DOI Listing

Publication Analysis

Top Keywords

resistance states
12
reconfigurable resistance
8
silver/polyethylene glycol
8
polymer melts
8
states
5
unveiling fundamental
4
fundamental principles
4
principles reconfigurable
4
resistance
4
states silver/polyethylene
4

Similar Publications

Refractory cytomegalovirus (CMV) infection is a severe complication following umbilical cord blood transplantation (UCBT). Antiviral agents, the standard first-line therapy, are limited by toxicity and resistance without robust T-cell immunity. We evaluated third-party donor (TPD)-derived CMV-specific T cells (CMVSTs) as a treatment option.

View Article and Find Full Text PDF

The complex interplay between circulating metabolites and immune responses, which is pivotal to disease pathophysiology, remains poorly understood and understudied in systematic research. Here, we performed a comprehensive analysis of the immune response and circulating metabolome in two Western European cohorts (534 and 324 healthy individuals) and one from sub-Saharan Africa (323 healthy donors). At the metabolic level, our analysis revealed sex-specific differences in the correlation between phosphatidylcholine and cytokine responses following ex vivo stimulation.

View Article and Find Full Text PDF

Epizootic hemorrhagic disease virus (EHDV) causes severe disease in ruminants. We assessed the pathogenicity of the Chinese EHDV-7 isolate YN09 in mice lacking the type I interferon receptor and in sheep. In mice, YN09 infection resulted in 100% mortality, with histopathological lesions, viral replication, and immunoreactivity in multiple organs.

View Article and Find Full Text PDF

Type I interferon (IFN-I) is highly prevalent in autoimmune disorders and is intricately involved in disease pathogenesis, including Sjögren's disease (SjD), also known as Sjögren's syndrome. Although the T follicular helper (Tfh) cell response has been shown to drive SjD development in a mouse model of experimental Sjögren's syndrome (ESS), the connection between IFN-I and the Tfh cell response remains unclear. As the activation of stimulator of interferon genes (STING) induces IFN-I production, we first demonstrated that mice deficient in STING or IFN-I signaling presented diminished Tfh cells and were completely resistant to ESS development.

View Article and Find Full Text PDF

Cancer development and response to treatment are evolutionary processes, but characterizing evolutionary dynamics at a clinically meaningful scale has remained challenging. Here we develop a new methodology called EVOFLUx, based on natural DNA methylation barcodes fluctuating over time, that quantitatively infers evolutionary dynamics using only a bulk tumour methylation profile as input. We apply EVOFLUx to 1,976 well-characterized lymphoid cancer samples spanning a broad spectrum of diseases and show that initial tumour growth rate, malignancy age and epimutation rates vary by orders of magnitude across disease types.

View Article and Find Full Text PDF